The effect of human recombinant interleukin-1 receptor antagonist on intestinal inflammation, tissue destruction, and bacterial invasion during experimental shigellosis caused by Shigella flexneri was studied in the rabbit-ligated loop infection model. Intravenous infusion of the inhibitor at a dose of 2 mg/kg per h, was initiated 30 min before intestinal loops were ligated and infected, and continued during the 8-h period of infection. The animals treated with IL-1 receptor antagonist showed a striking decrease in inflammation, destruction, and bacterial invasion of their tissues, both at the level of the villous intestine and Peyer's patches. This is conclusive evidence that interleukin-1 plays a critical role in the pathogenesis of shigellosis. This proinflammatory cytokine is here proposed as a major trigger of the inflammatory reaction which is characteristic of this invasive disease of the intestine, due to the particular interaction existing between S. flexneri and macrophages. 
Introduction
Shigellosis is an invasive disease of the human colon, caused by Shigella, a gram-negative bacillus of the family enterobacteriaceae. Children in developing areas are the principal victims of this disease which is largely caused, in its endemic form, by Shigella flexneri.
The clinical symptoms of shigellosis range from diarrhea to dysentery, characterized by fever, severe intestinal cramps, and emission of stools containing blood, pus, and mucus.
The disease is caused by penetration of invasive shigellae into the colonic and rectal mucosa. Intestinal cells are generally considered the primary target for the pathogen ( 1) . As recently reviewed, in vitro experiments demonstrate that Shigella has the capacity to establish efficient intracellular colonization of an epithelial layer by hijacking components of the host cell cytoskeleton both for entry and for cell to cell spread (2) .
Mutants unable to enter cells are avirulent in vivo, and those impaired in cell to cell spread express attenuated virulence in a model of dysentery in macaque monkeys (3) .
However, several observations indicate that shigellosis is not exclusively characterized by invasion of colonic and rectal epithelial cells. Acute inflammation occurring early after infection (4) by a small bacterial inoculum (5) may not only account for final mucosal destruction, but also, at an early stage, for disruption of the epithelial barrier, thus facilitating bacterial invasion through the basolateral pole of epithelial cells, which appears to be the essential site of entry (6) . This has recently been confirmed in vitro, by showing that invasive shigellae inoculated on the apical side of a differentiated monolayer of human colonic T84 cells are unable to invade these cells. On the other hand, they can promote strong transmigration of PMN deposited on the basal side, thus allowing invasion by opening of the paracellular pathway to the bacteria (7) . In a model of mucosal invasion in rabbit ligated intestinal loops, pretreatment of animals by infusion of an anti-CD18 monoclonal antibody which blocks immigration of PMN leukocytes into the mucosa, decreases bacterial invasion and prevents tissue destruction (8) . Shigellosis therefore resembles an acute inflammatory bowel disease, sharing significant clinical and histopathological similarities with ulcerative colitis.
Based on these data, we have recently started to investigate the pathogenesis of this acute inflammatory process. The macrophage appears to be a key player. In vitro, infected macrophages undergo apoptosis when infected with an invasive isolate of S. flexneri (9) . IpaB, a 62-kD invasin of this species accounts for induction of programmed cell death (10). The period preceding macrophage apoptosis is characterized by the release of large quantities of IL-la precursor and mature IL-1/ ( 11 ). A scheme emerges in which bacteria invade the intestinal barrier, essentially through M cells of the dome epithelium covering the lymphoid follicles of the mucosa (8, 12) . They are then rapidly translocated to local macrophages, trigger their apoptosis, thus achieving release of significant quantities of IL-1, and triggering a cascade of proinflammatory cytokines. This early inflammatory response is expected to spread from these areas and to destabilize the epithelium, thus facilitating bacterial invasion. We 
Methods
Bacterial strains and growth conditions. S. flexneri strain M90T, a serotype 5 invasive isolate (13) Intestinal segments of 10 cm in length were ligated, some of which contained a Peyer's patch. The blood supply was carefully preserved while ligation was performed. In each loop, 0.5 ml of a bacterial suspension containing 10.'0 bacteria/ml was injected. The abdominal cavity was then closed and animals were killed 8 h later. Ligated intestinal loops were dissected. The volume of fluid exudate was aspirated and measured. 1 ml of fluid was immediately frozen for dosage of TNF activity.
Depending on the next step, loops were either filled with 5 ml of a gentamicin solution (50 ,g/ml in 0.1 M PBS) for counting of invasive intracellular bacteria, or opened and dissected for histopathological analysis.
In each rabbit, eight loops were ligated, four corresponding to villous intestine and four to Peyer's patches. Therefore a total of 48 blocks of villous intestine and 48 blocks of Peyer's patches were submitted to histopathological analysis.
Bacterial counts in tissue samples. These experiments were performed as recently described (8 IL-Ira bioassay. Serum levels of perfused human IL-Ira were measured at 2 and 8 h after initiation of the perfusion, using the Quantikine IL-ira Immunoassay kit (Research & Diagnostics Systems, Minneapolis, MN). Similar measures were performed in control animals. In brief, the assay used a quantitative sandwich ELISA in which a monoclonal antibody specific for human IL-Ira was coated onto a microtiter plate.
After addition of serum samples, enzyme-linked polyclonal antibody specific for human IL-Ira was added, followed by washing and addition of the substrate. The enzymatic reaction was then stopped and the optical density read on a spectrophotometer. A standard curve was prepared to determine the actual concentration of IL-Ira present in each sample. TNF bioassay. Fluid aspirated from infected loops were stored frozen for subsequent TNF bioassay. WEHI 164 (clone 13) cells were seeded (3 x 104 cells/well) in 96-well plates and incubated for 24 h at 370C in 5% CO2. Supernatants, in six different dilutions, were added to the assay wells, RPMI-1640 was added to negative control wells, and TNF to positive control wells. Incubation was resumed for 20 h at 370C in 5% CO2. 125 Ag of MU (3-(4,5-dimethyl-thiazolyl-2-yl)-2,5-diphenyltetrazoliumbromide) in PBS was added to the wells and after 2 h of incubation at 37°C, the test was stopped with 100 isl of extraction Role of Interleukin-J in Shigellosis 885
buffer (20% SDS, 50% dimethylfonnamide in H20, 2.5% HCl 1 N, 2.5% of a 80% solution of acetic acid, pH 7.4). After overnight incubation at 370C, the absorbance was measured at 540 nm, using an automated microELISA autoreader (Dynatech MR4000; Dynatech, Guernesey, United Kingdom). One unit of TNFa activity was defined as the amount required to lyse 50% of WEHI 164 (clone 13) target cells (14).
Results
Control of the titers ofserum IL-Ira during the course of infection, with or without perfusion ofthe antagonist. These controls were carried out at 2 and 8 h of perfusion of 2 mg/kg per h of human recombinant IL-ira. As expected, very high serum titers of 23,282±5,649 pg/ml, and 27,757±1,163 pg/ml were, respectively, observed. Control animals infected with M9OT and perfused with saline showed titers -1,000 pg/ml, similar to those of noninfected animals. As the assay is not designed to dosing rabbit IL-lra, no conclusion can be drawn from these latter values.
Effect ofIL-Ira treatment on intestinal inflammation caused by S. flexneri. Three major criteria were used to assess the decrease of intestinal inflammation caused by continuous intravenous administration of IL-Ira during mucosal invasion by shigellae.
The volume of mucopurulent and often bloody exudate that constitutes the fluid produced in infected loops, correlates well with intensity of the inflammatory process, as already demonstrated (8) . As shown in Fig. 2 A, the average volume of exudate pooled from the eight ligated loops in each rabbit was three times higher in control animals (57.3±36.4 ml) than in animals treated with IL-lra (18.0±9.5 ml).
The amount of TNF present in the mucosal exudate has also been shown to correlate with the intensity of intestinal inflammation caused by Shigella invasion (8) . As shown in Fig. 2 Infiltration of the lamina propria with PMN. Upon observation of histopathological sections of intestinal tissues in control animals, we noticed that PMN were migrating into the connective tissue of the lamina propria and then on to the epithelial layer, by following two routes. One corresponded to PMN extravasating from the small vessels of the submucosa, crossing the muscularis mucosae, infiltrating the lamina propria between the crypts, transmigrating to the crypt lumen, thus causing cryptitis, and also migrating higher in the axis of the villus. Another route consisted in PMN extravasating from the blood capillaries present in the villus axis, directly invading the lamina propria of the villus, and proceeding to the basal side of the epithelial layer before transmigrating to the intestinal lumen, or destroying the basement membrane, thus causing detachment of the epithelium from the villus.
Based on this observation, PMN were counted in these two "compartments," crypt and villus axis. Results are shown in Fig. 3 was considered as an ulceration. According to these criteria, as shown in Fig. 3 villi, which is among the first symptoms of dysfunction in intestinal tissues (i.e., mucosal atrophy). The ratio between thickness of the submucosa and thickness of the entire mucosal plus submucosal layer, as it appeared that severe inflammation was reflected by major submucosal edema (see Fig. 5 A) . Fig. 4 Fig. 4 B. Control animals showed a high ratio of 0.42, reflecting the enormous edema that often characterized the submucosal layer of these animals. Conversely, the ratio of 0.07 observed in animals treated with IL-Ira was extremely low and equivalent to the ratio observed in noninfected loops (data not shown).
Length/Width (L/W) ratio of intestinal villi is shown in
Fine histopathological analysis of the lesions. Histopathological analysis was carried out both on sections of the villous intestine and on Peyer's patches.
Examination of villous intestinal tissues revealed significant differences between samples taken from control animals and animals treated with IL-Ira. As shown in Fig. 5 A, and already suggested in Figs. 3 and 4 , the villi of control animals were either reduced in length, or destroyed by a purulent necrotic process leaving vast areas of the crypt chorion infiltrated with PMN, and dissected by large hemorrhagic foci. Complete detachment of the epithelial layer was seen in many places. The subepithelial layer was characterized by enormous edema and infiltration of inflammatory cells, primarily PMN. Numerous PMN were seen immigrating from the vessels localized in the submucosa into the lamina propria surrounding the crypts, often leading to disruption of the muscularis mucosae.
In animals treated by IL-Ira, the histopathological aspect was strikingly different. Villi were consistently altered in length and shape, but never destroyed. As shown in Fig. 5 B, they often showed a "club-like" aspect, the tip of the villus being inflated by edema, whereas the basal half of the villus and the crypt area appeared normal. As suggested in Fig. 3 A, grating from the small and medium-size vessels of the submucosa, the other corresponding to the villus axis in which PMN seem to immigrate from local capillaries. This observation suggests that IL-Ira is mainly preventing the inflammatory process elicited at the crypt level, at a distance from the bacteria, whereas it is more difficult for IL-Ira to control inflammation elicited in areas of the villus that are in close contact with the offending microorganism. Histopathological examination of Peyer's patches also showed striking differences between control and IL-Ira-treated animals. In control animals, extensive destruction of the dome was consistently observed with intense edema and infiltration by PMN. In contrast, in IL-ira-treated animals, in spite of significant edematous reaction and infiltration by PMN, the dome was preserved or presented only few superficial ulcers of the epithelial layer. These results are summarized in Fig. 5 , C and D.
Bacterial invasion of mucosal tissues. As shown in Fig. 6 40 in the presence of ILira, whereas it was reduced only by a factor of 7 in Peyer's patches tissue. This probably indicated that the physiological capacity of the epithelial dome of Peyer's patches to internalize bacteria reduced the need for an inflammatory infiltrate to destabilize the epithelial structure and facilitate invasion.
In conclusion, based on all the criteria considered, treatment of animals with IL-ira caused significant protection against both Shigella invasion and intestinal tissue destruction.
Discussion
There is now evidence that IL-1 is involved in the pathogenesis of inflammatory bowel diseases (IBDs). On the other hand, there has been no investigation addressing the role of this proinflammatory cytokine in the pathogenesis of an invasive infection of the gut such as shigellosis.
Clinical and histopathological observations ( 15) , and recent experiments on the pathogenesis of shigellosis (8) , suggest that a pattern of acute inflammation is initiated at the early stage of intestinal invasion by S. flexneri, particularly in the lymphoid follicles associated with the mucosa. In addition to ultimately causing tissue destruction, inflammation is essential to disorganizing the epithelial barrier and facilitating bacterial invasion (8) . Macrophages present in the dome of lymphoid structures become infected by invasive shigellae, and some of them are rapidly killed. In vitro experiments have demonstrated that virulent S. flexneri causes apoptosis of infected macrophages (9) . Initiation of the cell death program in macrophages preactivated with LPS induces their release of large amounts of IL-la precursor and mature IL-1,3 (11) . These data suggest that releasing IL-1 may be a characteristic of resident macrophages present in the follicular dome of mucosal lymphoid structures when they phagocytose the invading pathogen. This population of macrophages, due to its permanent contact with bacterial products, particularly LPS, is probably more reactive to a pathogen like S. flexneri. In addition, M cells themselves have the capacity to produce IL-I after stimulation with LPS (16). Inflammation elicited in these areas may spread beyond lymphoid structures to the villous epithelium. In patients at the acute stage of shigellosis, immunohistochemical analysis of rectal biopsies, has shown a predominance of IL-i -producing cells, particularly in tissue samples showing signs of severe inflammation. Mononuclear cells, but also PMN and endothelial cells were the predominant IL-i -producing cell populations ( 17) . These experiments therefore point to IL-1 as a likely key player in the cascade causing the inflammatory process of shigellosis.
Similarly, current evidence indicates that IL-I plays a crucial role in colonic lesions in IBDs. This is suggested by clinical and experimental studies. Clinical transcribed and expressed at a significantly higher level by mononuclear cells purified from intestinal tissues of patients at the acute phase of IBD (16) (17) (18) (19) (20) (21) (22) (23) . In mice, recombinant IL-I alone has been shown to be able to induce intestinal pathology, particularly villus atrophy, crypt hyperplasia, and increase in number of intraepithelial lymphocytes (24, 25) . In the various animal models of ulcerative colitis, clear demonstration of the proinflammatory role of IL-1 has been provided by demonstrating the antiinflammatory effect of IL-Ira. Intravenous administration of this molecule before and during the development of rabbit immune complex colitis, significantly reduced all the parameters of intestinal inflammation and injury (26) . These data were further confirmed in a series of experiments showing that in a similar animal model, IL-lra did not alter the level of IL-la present in intestinal tissues, but induced a decrease in levels of proinflammatory molecules such as PGE2 and leukotriene B4 (27) . IL-Ira was also effective in reducing bowel inflammation in a model of rat colitis induced by local instillation of acetic acid (28) . In addition, in various experimental models, the receptor blocking activity of IL-Ira has significantly reduced the severity of diseases such as septic shock, lethal sepsis, and experimental arthritis (29) . The role of other inflammatory cytokines is less clear, although TN]Fa, IFNy, and IL-8 are good candidates to induce further inflammation and tissue destruction. Moreover, the chronic enterocolitis and ulcerative colitis patterns observed in interleukin-2 and interleukin-10-deficient mice harboring an intestinal flora (30, 31) suggest that these two cytokines, particularly IL-iO, a potent suppressor of macrophage activation in vitro (32), may be important negative regulators to consider in vivo in IBD as well as in shigellosis.
A major limitation to experimental approaches of shigellosis, however, is the lack of a reliable intestinal model of invasion. The guinea pig keratoconjunctivitis test is reliable to assess Shigella invasiveness but is irrelevant in this case. Mice do not develop rapid and consistent intestinal invasion by Shigella even in ligated loops. Alternatively, the rabbit-ligated loop assay appears sufficiently reliable to use it as a model of tissue invasion and inflammation. This allows us to consider using antagonists of proinflammatory molecules such as IL-lra. This inhibitor binds to both IL-1 receptors, but particularly relevant is its competitive binding to IL-i receptor 1 which blocks signal transduction induced by IL-ia and IL-l,6. It has no agonist effect and is produced by the same cells which produce IL-i with a delay of a few hours (33) . Rabbit IL-lra exhibits 77% amino acid sequence homology to the human molecule (34) . This high degree of conservation accounts for the capacity of human recombinant IL-Ira to antagonize rabbit IL-i. These characteristics made IL-lra the best candidate molecule to assess the role of IL-1 in shigellosis.
The present experiments have demonstrated that IL-Ira could significantly reduce the severity of intestinal lesions observed in rabbit experimental shigellosis as well as mucosal invasion by Shigella. The amount of circulating IL-ira obtained by perfusion of 2 mg/kg per h in rabbits reached values of 25,000 pg/ml similar to those obtained in human volunteers by perfusion of 10 mg/kg over a period of 3 h (i.e., 29,000 pg/ ml) (35) . The general structure of the intestinal epithelium was preserved in animals treated by the inhibitor, whereas massive destruction was observed in control animals. The amount of luminal exudate was reduced, as well as its content in TNF, an established parameter of the inflammatory process of experimental, but also natural shigellosis (8, 36) . In the complete pathogenic scheme, it is important to understand whether TNFa or IL-i is the primary initiator. We are currently conducting experiments with TNF inhibitors to address this point. We would also like to evaluate how much of the epithelial destruction observed in shigellosis is due to the high titer of TNFa produced and secreted intraluminally. These experiments also confirm our recent observation that the severity of mucosal inflammation accounts for the extent of mucosal invasion by the bacteria (7, 8) . It These observations validate the hypothesis that IL-I plays a significant physiopathological role in shigellosis and that the macrophage, which is a major producer of IL-1 (40) , is a key player in the pathogenesis of this disease, particularly in the lymphoid structures associated with the intestinal mucosa. In the current experimental system, after 8 h of intestinal infection in ligated loops, it is difficult to demonstrate a different reactivity of the lymphoid structures of Peyer's patches and of the villous intestine. Ligation of the intestine and high bacterial inoculum artificially facilitate invasion of the intestinal barrier. A closer model to human shigellosis is intragastric infection of macaque monkeys, followed by endoscopic observation of the colo-rectal mucosa as the disease develops (3). However, these experiments are almost impossible to achieve, particularly if constant infusion of IL-Ira needs to be maintained. The rabbit model, within well-defined limits, allows to draw conclusions on the role of IL-1 which would need definitive confirmation in a human trial as also suggested for IBD.
We believe that based on these observations, there is now solid ground to draw a parallel between shigellosis and some acute forms of IBD, particularly ulcerative colitis. In support of this idea, it is worth noting that the deleterious effect of IL-1 in experimental shigellosis appears rather specific of the causating pathogen Shigella. Indeed, in many other models of infection, such as Pseudomonas aeruginosa and Klebsiella pneumoniae (41) , Listeria monocytogenes (42), Salmonella typhimurium (43), Escherichia coli (44, 45) , and Mycobacterium avium (46), IL-i was shown to play a protective role, and IL-I blockade was reported to exacerbate the infectious process (47, 48) . This indicates that, as in IBDs, destructive inflammation is the predominant feature of shigellosis. Whether colonic destruction is the price to pay to eradicate Shigella from tissues, or whether these bacteria, even at low inoculum, can generate massive uncontrolled inflammation, remains to be analyzed.
Finally, it is not at all clear how shigellosis resolves. It as been shown that healthy human volunteers receiving E. coli endotoxin showed plasma levels of IL-1p6 peaking at 79 pg/ml, whereas their levels of IL-Ira, 1-3 h later were 100-fold higher (49) ..This excess amount of IL-lra may be sufficient to antagonize the biological effect of IL-1/3. Moreover, in acutely ill surgical patients, very high levels of IL-ira (i.e., 54,300 pg/ml) have been observed (50) . This indicates that serious conditions (with or without sepsis) may cause circulating levels of IL-ira equivalent to those obtained by perfusion, ranging between 1 and 10 mg/kg per h. We can therefore speculate that a physiological increase of IL-ira to high titers may be observed in the course of severe sepsis such as shigellosis. IL-ira titers produced locally by intestinal mononuclear cells and possibly other cell populations may account for efficient antagonism of IL-1p6, thus leading to healing.
